SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

QHSLab, Inc. USAQ OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

QHSLab, Inc. (USAQ) is a Medical - Devices company in the Healthcare sector, currently trading at $0.60. It has a SharesGrow Score of 60/100, indicating a above average investment profile with 3 out of 7 criteria passed.

Financials: revenue is $3M, +30.3%/yr average growth. Net income is $457,417, growing at +129.5%/yr. Net profit margin is 17% (healthy). Gross margin is 67.3% (+17.5 pp trend).

Balance sheet: total debt is $20,000 against $2M equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 1.96 (strong liquidity). Debt-to-assets is 0.9%. Total assets: $2M.

SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 100/100 (Pass), Past 25/100 (Fail), Health 67/100 (Partial), Moat 50/100 (Partial), Future ?/100 (Fail), Income 70/100 (Pass).

USAQ SharesGrow Score Overview

62/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 60/100

Valuation — P/E, PEG, Forward PEG

GROWTH 100/100

Financials — average growth

PAST 25/100

strong — trend

HEALTH 67/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 50/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 70/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — USAQ

USAQ trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

USAQ: +30.3%/yr revenue is, +129.5%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

USAQ: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet USAQ: Debt-to-Equity (D/E) ratio 0.01 (conservative), Current ratio is 1.96 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

USAQ: Gross margin is 67.3% (+17.5 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 50/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

USAQ: Net profit margin is 17%. healthy (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range0.08-1.136

Volume1K

Avg Volume (30D)3.75K

Market Cap$6.79M

Beta (1Y)0.45

Share Statistics

EPS (TTM)0.04

Shares Outstanding$11.3M

IPO Date2013-05-22

Employees4

CEOTroy James Grogan

Financial Highlights & Ratios

Revenue (TTM)$2.69M

Gross Profit$1.81M

EBITDA$785.56K

Net Income$457.42K

Operating Income$131.24K

Total Cash$636.16K

Total Debt$20K

Net Debt$-616.16K

Total Assets$2.17M

Price / Earnings (P/E)15

Price / Sales (P/S)2.52

Analyst Forecast

Company Info

CountryUS

ExchangeOther OTC

CurrencyUSD

ISINUS90350R1077

Price Chart

USAQ

QHSLab, Inc. ↗ · Other OTC

Healthcare • Medical - Devices

0.08 52WK RANGE 1.14

People Also View

Surmodics, Inc.

Tactile Systems Technology, Inc.

Apyx Medical Corporation

Rapid Micro Biosystems, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message